ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 53 filers reported holding ETON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $339,451 | +37.0% | 81,403 | +14.6% | 0.00% | – |
| Q2 2023 | $247,800 | -9.4% | 71,003 | 0.0% | 0.00% | – |
| Q1 2023 | $273,362 | -31.2% | 71,003 | -50.0% | 0.00% | – |
| Q4 2022 | $397,616 | +166.9% | 142,006 | +100.0% | 0.00% | – |
| Q3 2022 | $149,000 | -27.0% | 71,003 | -8.9% | 0.00% | – |
| Q2 2022 | $204,000 | -48.9% | 77,903 | -15.0% | 0.00% | – |
| Q1 2022 | $399,000 | +11.1% | 91,603 | +9.3% | 0.00% | – |
| Q4 2021 | $359,000 | -14.9% | 83,772 | 0.0% | 0.00% | – |
| Q3 2021 | $422,000 | -18.2% | 83,772 | 0.0% | 0.00% | – |
| Q2 2021 | $516,000 | -73.5% | 83,772 | -68.5% | 0.00% | – |
| Q1 2021 | $1,949,000 | -1.9% | 266,295 | +9.0% | 0.00% | – |
| Q4 2020 | $1,987,000 | +41.4% | 244,395 | +37.4% | 0.00% | – |
| Q3 2020 | $1,405,000 | +70.9% | 177,876 | +17.9% | 0.00% | – |
| Q2 2020 | $822,000 | – | 150,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,040,000 | $32,845,000 | 4.29% |
| AWM Investment Company, Inc. | 971,681 | $7,900,000 | 1.00% |
| Diametric Capital, LP | 51,633 | $420,000 | 0.33% |
| Mesirow Financial Investment Management, Inc. | 1,046 | $8,504,000 | 0.03% |
| Hood River Capital Management LLC | 76,397 | $621,000 | 0.02% |
| Westside Investment Management, Inc. | 83,900 | $4,743,000 | 0.01% |
| MML INVESTORS SERVICES, LLC | 129,250 | $1,051,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 31,961 | $260,000 | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 126,490 | $1,028,000 | 0.00% |
| SEI INVESTMENTS CO | 76,397 | $621,000 | 0.00% |